What Test Shows Insulin Resistance: Key Options

The most widely used test for insulin resistance is a fasting blood draw that measures both your blood sugar and insulin levels, then combines them into a score called HOMA-IR. A score of 1.0 is considered ideal, and values above 2.5 generally indicate insulin resistance. But HOMA-IR is just one option. Several other tests, from simple lipid ratios to multi-hour glucose challenges, can reveal insulin resistance at different stages, and some catch it years before standard blood sugar tests show any problem.

Fasting Insulin: The Simplest Starting Point

A fasting insulin test measures how much insulin your pancreas releases just to keep your blood sugar stable overnight. It requires a simple blood draw after 8 to 12 hours without eating. Standard lab reference ranges often list anything up to 25 μU/mL as “normal,” but many metabolic health experts recommend keeping fasting insulin under 10 μU/mL, with optimal levels often cited between 2 and 6 μU/mL.

This distinction matters. A fasting insulin of 18 μU/mL won’t get flagged on most lab reports, but it suggests your body is already working harder than it should to control blood sugar. The pancreas is compensating, pumping out extra insulin to force glucose into cells that have become less responsive. Your blood sugar may still look perfectly normal during this stage, which is why fasting glucose alone misses early insulin resistance.

HOMA-IR: The Standard Clinical Score

HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It combines your fasting insulin and fasting glucose into a single number using a straightforward formula: multiply your fasting insulin (in μU/mL) by your fasting glucose (in mg/dL), then divide by 405. A healthy person with normal insulin sensitivity scores around 1.0. Scores between 1.0 and 2.5 fall in the normal range, while anything above 2.5 points toward insulin resistance.

HOMA-IR is popular because it only requires one blood draw and gives clinicians a standardized way to track changes over time. If you lose weight, improve your diet, or start exercising, you can retest in a few months and see whether your score has dropped. The limitation is that it captures a single snapshot of fasting conditions. It doesn’t reveal how your body handles an actual meal, which is where dynamic tests come in.

The Oral Glucose Tolerance Test With Insulin

A standard oral glucose tolerance test (OGTT) has you drink 75 grams of glucose, then measures your blood sugar at the two-hour mark. It’s commonly used to diagnose prediabetes and diabetes. But adding insulin measurements at multiple time points throughout the test transforms it into a much more sensitive tool for detecting insulin resistance.

When insulin is measured alongside glucose at 30, 60, 90, and 120 minutes, the results show how hard your pancreas is working to clear that sugar from your blood. Two people can have identical glucose curves, both technically “normal,” while one requires three or four times more insulin to get there. That person is insulin resistant, and a standard OGTT without insulin measurements would miss it entirely.

Dr. Joseph Kraft pioneered this approach, collecting oral glucose tolerance data with insulin measurements from over 10,000 individuals. He identified five distinct insulin response patterns ranging from a normal response (Pattern I) through increasingly exaggerated insulin surges (Patterns II through IV) to a low-insulin response seen in advanced disease (Pattern V). Patterns II through IV all indicate hyperinsulinemia, where the body is overproducing insulin, often years before glucose levels rise enough to trigger a diabetes diagnosis.

The Triglyceride-to-HDL Ratio

You may already have a test result that hints at insulin resistance sitting in your medical records. Your standard lipid panel contains the numbers you need: divide your triglycerides by your HDL cholesterol. Research published in PLOS ONE found that the optimal cutoff for detecting insulin resistance in White European men was a ratio of 3.8 (using mg/dL units), while for women it was 2.0. South Asian men and women had lower thresholds of 2.8 and 2.5, respectively, reflecting differences in how insulin resistance manifests across ethnic groups.

This ratio works because insulin resistance changes the way your liver handles fats. Resistant cells don’t take up glucose efficiently, so the liver converts more of it into triglycerides. At the same time, HDL (the protective cholesterol) tends to drop. The combination of rising triglycerides and falling HDL creates a ratio that tracks surprisingly well with more expensive, specialized tests. It’s not precise enough to replace dedicated insulin testing, but it’s a useful screening tool you can calculate from routine bloodwork.

The Lipoprotein Insulin Resistance Score

Some advanced lipid panels now include a score called LP-IR, which stands for Lipoprotein Insulin Resistance. It analyzes six different characteristics of your cholesterol particles, including the size and number of your triglyceride-rich particles, LDL particles, and HDL particles. The score ranges from 0 to 100, with higher numbers indicating greater insulin resistance. Patients are typically grouped into quartiles: 0 to 20 (low risk), 21 to 40, 41 to 60, and above 60 (highest risk).

LP-IR captures something that standard cholesterol numbers miss. Two people can have the same total LDL cholesterol, but the person with insulin resistance tends to have more small, dense LDL particles rather than fewer large ones. This particle-level detail provides an additional window into metabolic health. LP-IR requires a specialized NMR (nuclear magnetic resonance) lipid panel, which not all labs offer, but it’s increasingly available through metabolic health clinics.

The Gold Standard: The Clamp Test

The hyperinsulinemic-euglycemic clamp is the definitive research tool for measuring insulin sensitivity. During the procedure, insulin is infused intravenously at a fixed rate while glucose is simultaneously dripped in and adjusted every 5 to 10 minutes to keep blood sugar locked in a narrow target range. The steady-state period occurs between 80 and 120 minutes, and the amount of glucose needed to maintain normal blood sugar during that window directly measures how sensitive your cells are to insulin. If you need a lot of glucose infused, your cells are responding well. If very little glucose is needed, your cells are resistant.

The clamp is precise, reproducible, and considered the benchmark against which all other insulin resistance tests are validated. It’s also expensive, time-consuming, requires IV lines and constant medical supervision, and is almost never used outside of research settings. For practical purposes, it’s the test that proves the other tests work, not one you’ll encounter in a doctor’s office.

Which Test to Ask For

If you suspect insulin resistance, the most practical first step is asking your doctor for a fasting insulin level alongside your routine fasting glucose. Many standard metabolic panels only include glucose, so you may need to specifically request insulin. Together, these two numbers let you calculate HOMA-IR and get a reliable picture of where you stand.

If your fasting numbers look borderline or you have risk factors like central obesity, a family history of type 2 diabetes, or polycystic ovary syndrome, a glucose tolerance test with insulin measurements at multiple time points provides a more complete picture. This extended version catches the compensatory hyperinsulinemia that fasting tests can miss, particularly in people whose bodies are still managing to keep fasting glucose in the normal range.

Your existing lipid panel offers a quick, free screen. Calculate your triglyceride-to-HDL ratio from your last blood work. If it’s elevated above the thresholds for your demographic, that’s another data point worth discussing with your provider. No single test is perfect in isolation, but combining fasting insulin, HOMA-IR, and your lipid ratio gives you a surprisingly thorough assessment without any specialized or expensive testing.